Priya Deshpande

647 total citations
14 papers, 180 citations indexed

About

Priya Deshpande is a scholar working on Nephrology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Priya Deshpande has authored 14 papers receiving a total of 180 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Nephrology, 5 papers in Pulmonary and Respiratory Medicine and 4 papers in Molecular Biology. Recurrent topics in Priya Deshpande's work include Renal cell carcinoma treatment (3 papers), Renal and related cancers (2 papers) and Renal Diseases and Glomerulopathies (2 papers). Priya Deshpande is often cited by papers focused on Renal cell carcinoma treatment (3 papers), Renal and related cancers (2 papers) and Renal Diseases and Glomerulopathies (2 papers). Priya Deshpande collaborates with scholars based in United States, Spain and Czechia. Priya Deshpande's co-authors include Rimda Wanchoo, Kenar D. Jhaveri, Teruko Kishibe, Kammi Henriksen, Shikha Wadhwani, Abhijat Kitchlu, Ziv Harel, Sarah E. Street, Ladan Golestaneh and Mariana Murea and has published in prestigious journals such as Blood, Annals of Oncology and Clinical Journal of the American Society of Nephrology.

In The Last Decade

Priya Deshpande

12 papers receiving 177 citations

Peers

Priya Deshpande
J.J. Boffa France
Priya Sriskandarajah United Kingdom
Ramzi Jeddi Tunisia
Laura Moi Switzerland
Helen Thomas United Kingdom
J.J. Boffa France
Priya Deshpande
Citations per year, relative to Priya Deshpande Priya Deshpande (= 1×) peers J.J. Boffa

Countries citing papers authored by Priya Deshpande

Since Specialization
Citations

This map shows the geographic impact of Priya Deshpande's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Priya Deshpande with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Priya Deshpande more than expected).

Fields of papers citing papers by Priya Deshpande

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Priya Deshpande. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Priya Deshpande. The network helps show where Priya Deshpande may publish in the future.

Co-authorship network of co-authors of Priya Deshpande

This figure shows the co-authorship network connecting the top 25 collaborators of Priya Deshpande. A scholar is included among the top collaborators of Priya Deshpande based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Priya Deshpande. Priya Deshpande is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Brém, Elizabeth, Wojciech Jurczak, David Belada, et al.. (2024). Odronextamab Monotherapy in Previously Untreated Patients with High-Risk Follicular Lymphoma (FL): Results of the Safety Lead-in of the Phase 3 Olympia-1 Study. Blood. 144(Supplement 1). 4411–4411. 2 indexed citations
2.
Nair, Girija, et al.. (2023). A Rare Case of Co-existing Non-small Cell Lung Carcinoma and Non-tuberculous Mycobacteria. Cureus. 15(12). e50456–e50456. 1 indexed citations
3.
Anand, Shuchi, et al.. (2023). Risk Amplifiers for Vascular Disease and CKD in South Asians. Clinical Journal of the American Society of Nephrology. 18(5). 681–688. 1 indexed citations
4.
Dieterich, Douglas T., et al.. (2022). Polycystic Kidney/Liver Disease. Clinics in Liver Disease. 26(2). 229–243. 9 indexed citations
6.
Street, Sarah E., et al.. (2021). Renal Cell Cancer and Chronic Kidney Disease. Advances in Chronic Kidney Disease. 28(5). 460–468.e1. 30 indexed citations
7.
Lee, Meghan, et al.. (2021). Chronic Kidney Disease in Cancer Survivors. Advances in Chronic Kidney Disease. 28(5). 469–476.e1. 8 indexed citations
8.
Deshpande, Priya, Mark A. Perazella, & Kenar D. Jhaveri. (2021). PARP inhibitors and the Kidney. 5(1). 42–47. 3 indexed citations
9.
Deshpande, Priya, Sunit Jariwala, Lily Martin, & Ladan Golestaneh. (2021). Impact of technology‐based interventions on linking potential kidney donors and transplant candidates: a scoping review. Transplant International. 34(12). 2781–2793. 2 indexed citations
10.
Kitchlu, Abhijat, Kenar D. Jhaveri, Shikha Wadhwani, et al.. (2020). A Systematic Review of Immune Checkpoint Inhibitor–Associated Glomerular Disease. Kidney International Reports. 6(1). 66–77. 89 indexed citations
11.
Deshpande, Priya. (2020). Increasing percentage of ‘Early Menarche’ in Indian adolescent girls and it’s prevention. 6(1). 49–51. 1 indexed citations
12.
Deshpande, Priya & Kenar D. Jhaveri. (2019). The role of the kidney in AL amyloidosis. Nephrology Dialysis Transplantation. 36(9). 1597–1599.
13.
Deshpande, Priya, et al.. (2011). Acute kidney injury as a causal factor in mortality associated with hepatorenal syndrome. Hepatology International. 5(3). 751–758. 9 indexed citations
14.
Deshpande, Priya, et al.. (2010). Meropenem removal in critically ill patients undergoing sustained low-efficiency dialysis (SLED). Nephrology Dialysis Transplantation. 25(8). 2632–2636. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026